Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02992899 · ClinicalTrials.gov registry record · Phase 3
Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder
A Phase 3 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT02992899 is a Phase 3 study that has completed, run by Emory University. The registered enrollment target is 56 participants.
The verdict
NCT02992899, a Phase 3 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
The tasks of the project are to map the potency and kinetics of the neurologic, autonomic peripheral, inflammatory, and behavioral responses to vagal nerve stimulation (VNS) vs. sham treatment, at baseline and in response to stressful traumatic scripts related to personal traumatic events, as well as a series of other stressors.
Interventions
- DEVICE GammaCore/electroCore non-invasive VNS device
- DEVICE Sham gammaCore/electroCore
- DRUG O-15 water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-04-19 |
| Est. Completion | 2019-09-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02992899
The ClinicalTrials.gov registry entry for NCT02992899 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which GammaCore/electroCore non-invasive VNS device is the first listed.
NCT02992899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02992899 about?
NCT02992899 is a clinical study titled "Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder". The tasks of the project are to map the potency and kinetics of the neurologic, autonomic peripheral, inflammatory, and behavioral responses to vagal nerve stimulation (VNS) vs. sham treatment, at baseline and in response to stressful traumatic scripts related to personal traumatic events, as well a...
What is the current status of trial NCT02992899?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2017-04-19. Estimated completion is 2019-09-21.
What interventions are being tested in trial NCT02992899?
The interventions under investigation include: GammaCore/electroCore non-invasive VNS device (DEVICE), Sham gammaCore/electroCore (DEVICE), O-15 water (DRUG).
Who is sponsoring clinical trial NCT02992899?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.